Eventide Healthcare & Life Sciences Fund Cl N (ETNHX) Forecast
See the Price Targets and Ratings of:
ETNHX Analyst Rating
Moderate Buy
78ConsensusRatings
54Buy24Hold0Sell
Based on the Wall Street analyst consensus for 78 of ETNHX’s holdings.
ETNHX Analyst Price Target
Average Price Target
$91.84▲(76.11% Upside)
Based on Wall Street analyst 12-month price targets for 78 of Eventide Healthcare & Life Sciences Fd Cl N’s holdings in the last 3 months. The average price target is $91.84 with a high forecast of $117.09 and a low forecast of $66.82. The average price target represents a 76.11% change from the last price of $52.15.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$117.09
Average$91.84
Low$66.82
Past 12 Months12 Month Forecast$43$61.8$80.5$99.3$118Feb2026May2026Aug2026Nov2026Nov2027
What is ETNHX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 78 of ETNHX’s holdings, Eventide Healthcare & Life Sciences Fd Cl N’s 12-month average price target is $91.84.
What is ETNHX’s upside potential, based on the analysts’ average price target?
ETNHX’s average price target of $91.84 represents a 76.11% upside from its last price of $52.15.
Is ETNHX a Buy, Sell or Hold?
Eventide Healthcare & Life Sciences Fd Cl N has a consensus rating of Moderate Buy, based on the analyst consensus for 78 of ETNHX’s holdings: 54 rated Buy, 24 rated Hold and 0 rated Sell.
What is Eventide Healthcare & Life Sciences Fd Cl N’s price target?
The average price target for Eventide Healthcare & Life Sciences Fd Cl N is $91.84, based on Wall Street analyst 12-month price targets for 78 of ETNHX’s holdings, issued in the past 3 months. The highest price target is $117.09 and the lowest is $66.82. The average price target represents a 76.11% increase from the last price of $52.15.
How can I buy shares of ETNHX?
You can buy shares of ETNHX through a brokerage account. Compare brokers on our Best Online Brokers page.